Page last updated: 2024-12-07

inositol 1,3,4-trisphosphate

Description

1D-myo-inositol 1,3,4-trisphosphate(6-) : The hexaanion of 1D-myo-inositol 1,3,4-trisphosphate. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID25201948
CHEBI ID58414
MeSH IDM0162210

Synonyms (10)

Synonym
(1s,2s,3s,4s,5r,6r)-3,5,6-trihydroxycyclohexane-1,2,4-triyl tris(phosphate)
1d-myo-inositol 1,3,4-trisphosphate(6-)
CHEBI:58414
inositol 1,3,4-trisphosphate
1-d-myo-inositol (1,3,4)-trisphosphate
ins(1,3,4)p3
d-myo-inositol (1,3,4)-trisphosphate
MMWCIQZXVOZEGG-MLQGYMEPSA-H
Q27125773
[(1s,2r,3r,4s,5s,6s)-2,3,5-trihydroxy-4,6-diphosphonatooxycyclohexyl] phosphate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
inositol phosphate oxoanionAny organophosphate oxoanion derived from an inositol phosphate.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (47)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.13)18.7374
1990's35 (74.47)18.2507
2000's5 (10.64)29.6817
2010's6 (12.77)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other46 (97.87%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
chemdatabank.com